Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial

Authors

Jiali Sun (ORCID: https://orcid.org/0000-0003-4915-8266)
Wenwen Guo (ORCID: https://orcid.org/0000-0001-9594-1783)
Sizhou Feng (ORCID: https://orcid.org/0000-0001-5304-3301)
Qianxia Ma (ORCID: https://orcid.org/0000-0002-6635-2792)
Erlie Jiang (ORCID: https://orcid.org/0000-0003-0237-6063)
Wenbin Cao (ORCID: https://orcid.org/0000-0002-5507-1936)
Rongli Zhang (ORCID: https://orcid.org/0000-0002-1940-7295)
Jialin Wei (ORCID: https://orcid.org/0000-0002-0072-5461)
Zhenyun Liu (ORCID: https://orcid.org/0000-0001-8256-5176)
Aiming Pang (ORCID: https://orcid.org/0000-0003-3706-3139)
Xin Chen (ORCID: https://orcid.org/0000-0002-5310-5426)
Qiang Li
Fengjiao Wang (ORCID: https://orcid.org/0009-0006-8829-1536)
Yi He
Kuo Fang
Mingzhe Han (ORCID: https://orcid.org/0000-0002-7899-2375)
Mingjun Xu (ORCID: https://orcid.org/0000-0001-5585-7712)
Liang Chen (ORCID: https://orcid.org/0000-0001-8339-8592)
Donglin Yang
Lin Li (ORCID: https://orcid.org/0009-0004-8777-6983)
Weihua Zhai
Yigeng Cao (ORCID: https://orcid.org/0000-0002-9097-8103)

Institutions

Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Institute of Hematology & Blood Diseases Hospital (CN)

Publication Details

Journal: Frontiers in Immunology
Published: 2025-11-28
DOI: https://doi.org/10.3389/fimmu.2025.1626775
Primary Topic: COVID-19 Clinical Research Studies
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Natural Science Foundation of China
National Science and Technology Major Project
National Key Research and Development Program of China
Fundamental Research Funds for the Central Universities

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial

Jiali Sun, Wenwen Guo, Sizhou Feng, Qianxia Ma et al.

Nov 28, 2025

Frontiers in Immunology

COVID-19 Clinical Research Studies

article

Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial

Jiali Sun, Wenwen Guo, Sizhou Feng, Qianxia Ma, Erlie Jiang, Wenbin Cao, Rongli Zhang, Jialin Wei, Zhenyun Liu, Aiming Pang, Xin Chen, Qiang Li, Fengjiao Wang, Yi He, Kuo Fang, Mingzhe Han, Mingjun Xu, Liang Chen, Donglin Yang, Lin Li, Weihua Zhai, Yigeng Cao

November 28, 2025article en

Abstract

No abstract available for this paper.

Frontiers in ImmunologyVol. 16

Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Institute of Hematology & Blood Diseases Hospital (CN)

National Natural Science Foundation of China, National Science and Technology Major Project, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities

Openalex Percentile: Top 57%

COVID-19 Clinical Research Studies

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial — Jiali Sun, Wenwen Guo, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS